We use essential cookies for the site to work and optional analytics and marketing cookies. You can accept or reject them — your choice can be changed at any time. Learn more
Tratamento
How retatrutide, CagriSema and tirzepatide work, what trials still need to prove, and how a new GLP-1 medicine could reach Brazil through Anvisa.
A practical checklist for when Ozempic seems to stall: dose timing, storage, injection technique, health factors, and what to bring to your doctor.
Starting a GLP-1 medication after 60 raises different questions than starting at 40. Here is what seniors and caregivers should track once the pen is in hand.
Planning an Ozempic to Brazilian semaglutide switch? Learn how to read the pen, time your dose, track your weight, and keep your supply steady.
Switching between Ozempic and Mounjaro can change how fast you see results. Here is what to expect week by week, in both directions, and what to track.
Canetas emagrecedoras no SUS ainda são um processo em andamento. Veja a diferença entre aprovação, recomendação e dispensação e o que checar antes de agir.
O lipoless paraguaio promete gordura reduzida sem cirurgia. Veja o que o termo significa, o que a evidência mostra e o que checar antes de agendar.
Is retatrutide really stronger than Mounjaro? We check the trial numbers, the mechanism behind the claim, the side effect signals, and why head-to-head comparisons are tricky.
Understanding the glycemic mechanism behind semaglutide reveals why it works for metabolic health beyond just diabetes management.
Curious about using GLP-1 weight loss pens for months or years? Here is what clinical research really says about safety, tolerance, and what happens when you stop.
